2022
DOI: 10.1016/j.exer.2022.109248
|View full text |Cite
|
Sign up to set email alerts
|

Systems genomics in age-related macular degeneration

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 13 publications
(7 citation statements)
references
References 107 publications
(164 reference statements)
0
7
0
Order By: Relevance
“…12 This study identified a variant in the CFH locus that associates with idiopathic MFC. This risk variant is in full LD with rs10922109, a variant that is associated with age-related macular degeneration (AMD) 23,24,27 and rs1410996 that has previously been associated with MFC using targeted SNV analysis carried out on 48 cases. 13 Among the established genetic loci associated with AMD, 28 we detected only a suggestive association for another variant in the CFH gene (rs570618 LD = 0.99 with rs1061170[Y402H]; P = 1.1 × 10 −5 ) (eTable 7 in Supplement 2).…”
Section: Discussionmentioning
confidence: 97%
“…12 This study identified a variant in the CFH locus that associates with idiopathic MFC. This risk variant is in full LD with rs10922109, a variant that is associated with age-related macular degeneration (AMD) 23,24,27 and rs1410996 that has previously been associated with MFC using targeted SNV analysis carried out on 48 cases. 13 Among the established genetic loci associated with AMD, 28 we detected only a suggestive association for another variant in the CFH gene (rs570618 LD = 0.99 with rs1061170[Y402H]; P = 1.1 × 10 −5 ) (eTable 7 in Supplement 2).…”
Section: Discussionmentioning
confidence: 97%
“…Furthermore, there was a progressive loss of MCT3 with an increasing severity of dry AMD [ 96 ]. An increase in the expression of HTRA1 protein was reported in iPSC-RPE cell line from subjects carrying a high-risk genotype at 10q26 locus [ 65 , 128 ], and a clinical trial evaluating the inhibition of HTRA1 is ongoing [ 129 ]. Mutations in RDH5 have been reported in a subset of patients with macular atrophy [ 63 , 130 ].…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, there was a progressive loss of MCT3 with increasing severity of dry AMD [125]. Increase in expression of HTRA1 protein was reported in iPSC-RPE cell line from subjects carrying high risk genotype at 10q26 locus [66,126,127] and a clinical trial evaluating inhibition of HTRA1 is ongoing [128]. Mutations in RDH5 have been reported in a subset of patients with macular atrophy [64,129].…”
Section: Discussionmentioning
confidence: 99%